Stockholm, Sweden — Medivir AB (OMX: MVIR) today announced the Nomination Committee’s proposal for a new Board of Directors that will be submitted to the 2015 Annual General Meeting. The 2014-2015 Nomination Committee comprises representatives of the company’s three largest shareholders at the end of the third quarter of 2014 who have accepted a seat on the Nomination Committee, and the Chairman of the Board. The composition of the 2014-2015 Nomination Committee was as follows: · Anders Algotsson, Chairman of the Nomination Committee, representing AFA Försäkring · Maria Rengefors, representing Nordea Fonder · Birgitta Stymne Göransson, Chairman of the Board of Medivir AB · Bo Öberg, representing the class A shareholders The Nomination Committee has agreed, ahead of the upcoming 2015 Annual General Meeting, to propose that a new Board of Directors be appointed by means of the re-election of the Board’s existing Members, namely Anna Malm Bernsten, Anders Ekblom, Anders Hallberg, Bertil Samuelsson and Birgitta Stymne Göransson, and the new election of two Members, namely Johan Harmenberg and Helena Levander. The Committee also proposes the re-election of Birgitta Stymne Göransson as Chairman of the Board. Björn C. Andersson has declined re-election and Niklas Prager resigned his seat on the Board in September 2014 in conjunction with his appointment as President & CEO of the company. Johan Harmenberg, born 1954, is a physician, Doctor of Medicine, and an Associate Professor of Virology at the Karolinska Institute, and has conducted scientific research work at MIT in Cambridge, Mass., USA. Johan is currently the Chief Medical Officer of Glionova AB and Oncopeptides AB, and has previously worked as a researcher, Chief Medical Officer, and Development Manager at, amongst others, Roche, Astra, Pharmacia & Upjohn, Medivir and Algeta ASA. Johan is also a former CEO of Axelar AB and Akinion AB and Member of the Boards of Light-up AB and Oxypharma AB. He has published over 100 scientific papers and abstracts, mainly on pharmaceuticals and the development of pharmaceuticals for the treatment of cancer and infectious diseases. Helena Levander, born 1957, gained a degree in Business Administration from the Stockholm School of Economics. Helena is a founder and Chairman of the Board of Nordic Investor Services AB and has extensive experience of corporate governance issues. Helena has previously worked for companies such as Neonet, Odin Förvaltning, Nordea Asset Management and SEB Asset Management. She is a Member of the Boards of Concordia Maritime AB, Hans Andersson Recycling AB, NeuroVive Pharmaceutical AB, Collector AB, Uniflex Bemanning AB and Stampen AB, and a former Member of the Boards of a number of companies, including Gant AB, Transatlantic AB, Nordisk Energiforvaltning ASA, Svensk Exportkredit AB (SEK), Bure Equity AB, Mandator AB, Geveko AB, Erik Penser Bankaktiebolag and SBAB Bank AB. For further information, please contact: Anders Algotsson, AFA Försäkring +46 (8) 696 40 67 About Medivir Medivir is a research based pharmaceutical company with a research focus on infectious diseases and oncology. We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet great unmet medical need. Our commercial organization provides a growing portfolio of specialty care pharmaceuticals on the Nordic market. Medivir is listed on the Nasdaq Stockholm Mid Cap List.
Medivir’s Nomination Committee proposes new Board of
Top 10 Most Recent News Articles
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore
Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...
Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC
New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...
Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle
Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...
Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese
Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...
Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial
Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...
Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026
Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...
Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies
Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...
Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move
Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...
Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety
Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...
Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue ReadingTop 5 Most Recently Viewed Articles
WellCare of Kentucky Partners with Owen County for Transit Grant
WellCare of Kentucky Collaborates with Owen County for a Transportation Grant Improving transportation access for rural residents is essential to reducing barriers for medical visits and other important commitments. WellCare of Kentucky has announced a significant initiative that reflects this commitment by awarding Owen County Public Transit (OCPT) a grant worth $20,000....
Continue Reading
Domo Delivers Strong Growth in Q3 Fiscal 2025 Results
Domo Reports Impressive Third Quarter Fiscal 2025 Results Domo, Inc. (Nasdaq: DOMO) has recently released its financial results for the fiscal third quarter, revealing significant growth and promising outlooks for the future. The company recorded a total revenue of $79.8 million, marking a strong performance driven by a $71.1 million subscription revenue component. The...
Continue Reading
Goodfellow Inc. Announces Q3 Earnings and Dividend Update
Goodfellow Inc. Declares Q3 Financial Results and Dividend Goodfellow Inc. (TSX: GDL), a prominent name in the wood manufacturing and distribution sector, has recently shared its financial performance for the third quarter. Reporting net earnings of $5.8 million, or $0.68 per share, the figures show a slight decline from last year when net earnings reached $6.2 million at...
Continue Reading
Engagement and Health Awareness at ¡Vive Tu Vida! Event
Engagement and Health Awareness at ¡Vive Tu Vida! Event The Mexican American Opportunity Foundation (MAOF) is set to host a spectacular health and wellness fair known as ¡Vive tu vida! Get Up! Get Moving!, where families will gather to celebrate health and promote physical activity. This much-anticipated event underscores the importance of community involvement in...
Continue Reading
Orca Scan Unveils Innovative Tool for Effortless Barcode Design
Revolutionizing Barcode Generation with Orca Scan Creating barcodes has now become more accessible thanks to Orca Scan, a dynamic player in the software industry. The company recently unveiled an innovative barcode label designer aimed at streamlining the barcode creation process for users worldwide. This new tool provides enhanced functionality for businesses seeking...
Continue Reading